Insulin Analog 1 Diabetes Market by Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs [Aspart, Glulisine, and Lyspro], and Premix Insulin Analogs), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

According to the report, global demand for insulin analog 1 diabetes market was valued at approximately USD 5,796.3 Million in 2019, and is expected to generate revenue of around USD 9,742.3 Million by end of 2026, growing at a CAGR of around 7.7% between 2020 and 2026.

17-Oct-2020 | Number of pages: 110 | Report Code: ZMR-2920 | Report Format : | Status : Published

Abstract

According to the report, global demand for insulin analog 1 diabetes market was valued at approximately USD 5,796.3 Million in 2019, and is expected to generate revenue of around USD 9,742.3 Million by end of 2026, growing at a CAGR of around 7.7% between 2020 and 2026.

Type 1 diabetes is a multifactorial chronic and autoimmune condition during which the body produces little or no insulin in the pancreas. Insulin hormone is needed by the body to get glucose from the bloodstream into the cells to produce energy. Most of the diabetes cases can be classified as type 1a – autoimmune disease, where the destruction of pancreatic beta cells is observed, low production of insulin disrupts blood glucose homeostasis and minor cases of type 1b – idiopathic diabetes mellitus. This type of diabetes is rare and develops during childhood or adolescence, but can also be seen in adults. Frequent urination, excessive thirst, increased hunger, weight loss, and fatigue are some of the typical symptoms. Diabetes diagnostic devices encompass test strips, lancets, analog blood meter along with insulin delivery devices such as insulin syringe, insulin pump, insulin pen and insulin jet injectors.

The global type 1 diabetes market is expected to bolster at a significant growth rate over the forecast period due to the decisive use of insulin for treatment of the disease along with increasing use of insulin delivery apparatus. Unhealthy food habits, rising obesity rates, and sedentary lifestyle are key contributing factors fueling the growth of global type 1 diabetes market. Government initiatives for diabetes control, the economic impact of the disease on the healthcare systems of several countries calls for growth of the market. Whereas, hostile reimbursement policies and high costs of diagnosis and treatment are restraining factors for the growth of global type 1 diabetes market. The innovation of newer molecules from newer class of diabetic drugs along with a strong pipeline would be an opportunity for growth along with an extension in development of non-invasive diabetes diagnostics and drug delivery devices can also be seen as an opportunity. Considering the side effects associated with the treatment therapies of type 1 diabetes could be seen as a challenge for the growth of the market.

The report covers forecast and analysis of the insulin analog 1 diabetes market on a global and regional level. The study provides historic data of 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the aircraft engine market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein insulin analog segments are benchmarked based on their market size, growth rate and general attractiveness.

Global type 1 diabetes market is segmented on the basis of insulin analog as rapid-acting insulin analogs, long-acting insulin analogs, and premix insulin analogs. Rapid-acting insulin segment is further classified into aspart, glulisine, and lyspro. Rapid action segment is anticipated to expand at a significant growth rate over the forecast period attributed to increased uptake of the novel formulations.

Regionally, the insulin analog 1 diabetes market is divided into Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. Among the aforementioned regions, type 1 diabetes market is dominated in North America owing to increasing cases of diabetes in the region. The U.S. is emerging as the power market with a significant number of children below fourteen years who have type 1 diabetes compared to other countries in the region. Asia-Pacific is expected to record the substantial growth rate during the forecast period attributed to rise in the aging population in the region, with India emerging as the potential leader for the market within a forecast period.

Some of the players of insulin analog 1 diabetes market included in report are Eli Lilly and Company, Bayer Pharmaceuticals, Sanofi, Novo Nordisk, AstraZeneca Plc, XOMA Corp., DiaVacs, Inc., B. Braun Melsungen AG, Biodel, Inc., Macrogenics, Inc., and Takeda Pharmaceutical among others.

The report segments the global insulin analog 1 diabetes market into:

Global Insulin Analog 1 Diabetes Market: Insulin Analog Segment Analysis

  • Rapid-Acting Insulin Analogs
    • Aspart
    • Glulisine
    • Lyspro
  • Long-Acting Insulin Analogs
  • Premix Insulin Analogs

Global Insulin Analog 1 Diabetes Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Related Reports

Dexamethasone Market by Formulation type (liquid, Tablet, Solution for injection, Other), by Patient type (Adult, Pediatric, and Geriatric), by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, COVID-19, and Others), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5369 | Report Format:

The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Dexamethasone market alo...Read More

Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5362 | Report Format:

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counte...Read More

Global Remdesivir Market - by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5358 | Report Format:

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along wit...Read More

Immunity Booster Market - by Nature (Organic, Conventional), by Source (Plant-based, Animal-based, Other), by Form (Tablets, Capsules, Powder, Liquid), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacy & Drug Stores, and Online Retail) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5357 | Report Format:

The report covers forecast and analysis for the Immunity booster market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Immunity booster mark...Read More

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Request Free Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.